Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIDENT
PACTR201907745723209Phase 3Recruiting
- Sponsor
- The George Institute for Global Health
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of telmisartan, amlodipine and indapamide in intracerebral hemorrhage (ICH) and hypertension (HTN) (2 arms), sponsored by The George Institute for Global Health. Primary endpoint: Time to first recurrent stroke. Started Sep 2019; status: recruiting.
02
Drugs
telmisartanamlodipineindapamide
03
Conditions
intracerebral hemorrhage (ICH)hypertension (HTN)
Beyond the preview
Go deeper on PACTR201907745723209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201907745723209.